ArticleOncotarget2017

miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer.

Mingxin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.